BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

May 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-04-30

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-30	Common Stock	A	908	$51.2635	Acquired	252159	Direct
2015-05-01	Common Stock	M	23218	$6.46	Acquired	56476	Indirect
2015-05-01	Common Stock	S	23218	$114.9762	Disposed	33258	Indirect
2015-05-01	Common Stock	S	3505	$114.9762	Disposed	248654	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-01	Stock Option (right to buy) Common Stock	$6.46	M	23218	Disposed	2015-05-10	Common Stock (23218)	Indirect

Footnotes

F1: The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2014 to April 30, 2015.

F2: Trade made pursuant to a 10b5-1 plan executed October 28, 2014.

F3: The reporting person an his spouse act as trustees for the Bienaime Family Trust

F4: The price in column 4 is an average weighted price. The price actually received ranged from $112.80 to $119.50. The issuing person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.

F5: Original option grant vests 6/48th on November 11, 2005, and 1/48th on the 11th day of every month thereafter.

F6: Reflects the numbers of stock options outstanding after the transaction from this specific stock option grant.